KR20200145254A - Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng - Google Patents

Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng Download PDF

Info

Publication number
KR20200145254A
KR20200145254A KR1020190074007A KR20190074007A KR20200145254A KR 20200145254 A KR20200145254 A KR 20200145254A KR 1020190074007 A KR1020190074007 A KR 1020190074007A KR 20190074007 A KR20190074007 A KR 20190074007A KR 20200145254 A KR20200145254 A KR 20200145254A
Authority
KR
South Korea
Prior art keywords
ginseng
cognitive function
ginsenosides
brain function
composition rich
Prior art date
Application number
KR1020190074007A
Other languages
Korean (ko)
Inventor
백진수
권이성
김병환
이정기
Original Assignee
제너럴네이처주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제너럴네이처주식회사 filed Critical 제너럴네이처주식회사
Priority to KR1020190074007A priority Critical patent/KR20200145254A/en
Publication of KR20200145254A publication Critical patent/KR20200145254A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065Microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a method for preparing a composition rich in ginsenosides Rg3, Rg5, and Rk1 having excellent brain function and cognitive function improvement effects using ginseng, wherein the method comprises the following steps: (a) pulverizing fresh ginseng to obtain a pulverized fresh ginseng; (b) putting the pulverized fresh ginseng in a microwave-only container, closing a lid of the container, and performing heat treatment using microwave; (c) inoculating Lactobacillus plantarum MH16 in a medium, followed by culturing and sterilizing the same to prepare a treatment solution for treating the fresh ginseng completed in step (b); and (d) adding fresh ginseng heat-treated through the step (b) to the treatment solution prepared in the step (c), followed by aging the same.

Description

인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법{Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng}Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain by using ginseng function and cognitive function using ginseng}

본 발명은 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1의 함량을 인삼으로부터 증가시키는 제조방법으로서, 상세하게는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법에 관한 것이다.The present invention is a manufacturing method for increasing the content of ginsenosides Rg3, Rg5, and Rk1, which are excellent in improving brain function and cognitive function, from ginseng, and in detail, ginsenosides having excellent effect on improving brain function and cognitive function using ginseng It relates to a method for preparing a composition rich in Rg3, Rg5, and Rk1.

4 내지 6년 근의 인삼을 경작지에서 수확하여 가공하지 않은 원형 그대로의 인삼을 수삼이라고 하며 건조하지 않았기 때문에 생삼이라고도 한다. 수삼은 보통 75% 내외의 수분을 함유하고 있어 채굴된 상태 그대로는 1주 이상의 저장이 어렵고 특히 유통과정 중에 부패하거나 손상이 일어나기 쉽기 때문에 인삼의 장기 보존을 위하여 수분 탈취식의 가공을 하게 된다. Ginseng from 4 to 6 years old is harvested on the farmland and unprocessed in its original form. It is also called fresh ginseng because it is not dried. Fresh ginseng usually contains about 75% moisture, so it is difficult to store it for more than one week as it is mined. Especially, it is prone to spoilage or damage during distribution, so it is processed in a moisture deodorant type for long-term preservation of ginseng.

인삼이 함유하는 다양한 약리작용 및 생리활성에 관여하는 성분은 사포닌으로 타 식물 사포닌과 구별하기 위해서 인삼(ginseng)에서 분리된 배당체(glyco-side)로서 진세노사이드라고 명명하고 있으며 주로 중추신계를 비롯하여 내분비계, 면역계, 대사계 등에 영향을 미쳐 신체기능 조절에 다양한 효과를 발휘한다. 현재까지 정제 및 분리 분석 기술에 의해 고려인삼(수삼)으로부터 38종의 진세노사이드가 분리되어 그 화학구조가 밝혀졌으며, 열 숙성분해 과정을 거치면서 인삼의 활성성분이 밖으로 흘러나가지 않고 사포닌 함량과 기타 유효 성분들이 증가하고 이 과정에서 본래 인삼이 가지고 있지 않은 새로운 진세노사이드 성분이 생성된다.The component involved in various pharmacological and physiological activities of ginseng is saponin, and it is named ginsenoside as a glyco-side isolated from ginseng to distinguish it from other plant saponins. By affecting the endocrine system, immune system, and metabolic system, it exerts various effects in regulating body functions. Until now, 38 kinds of ginsenosides have been separated from Korean ginseng (fresh ginseng) by purification and separation analysis technology, and their chemical structure has been revealed.The active ingredient of ginseng does not flow out and the saponin content and Other active ingredients increase, and in this process, new ginsenosides that ginseng does not have are produced.

진세노사이드의 체내 흡수율을 증진시키고 효능의 표준화를 위해 인삼을 특정 미생물로 발효하여 얻어진 것을 발효인삼이라고 하며, 고분자의 진세노사이드는 그 자체로 인체에 흡수되지 않고 장내 미생물에 의해 분자량이 작은 진세노사이드 대사물로 분해되어 흡수되기 때문에, 고분자 진세노사이드를 저분자 진세노사이드로 얻기 위한 효과적인 방법으로 발효 공정을 이용하고 있다. 하지만, 기존의 발효 방법에서도 저분자 진세노사이드로 전환되는 수율이 낮거나 특정 저분자 진세노사이드를 얻을 수 없는 문제점이 있다.Fermented ginseng is obtained by fermenting ginseng with specific microorganisms to improve the absorption rate of ginsenosides in the body and to standardize efficacy. The polymeric ginsenosides are not absorbed by the human body by themselves and have a small molecular weight by the intestinal microorganisms. Since it is decomposed and absorbed by senoside metabolites, a fermentation process is used as an effective method for obtaining high molecular weight ginsenosides as low-molecular ginsenosides. However, even in the conventional fermentation method, there is a problem in that the yield of conversion to low-molecular ginsenoside is low or a specific low-molecular ginsenoside cannot be obtained.

인삼을 가공 처리하여 진세노사이드를 증가시키는 방법의 가공삼으로는 대표적으로 홍삼과 흑삼이 있으나, 홍삼과 흑삼은 찌고 말리는 증숙과 건조과정으로 인해 중량의 급격한 감소와 발암물질인 벤조피렌의 생성 및 복잡한 제조공정으로 인한 제조비용 증가 등의 단점을 지니고 있으며, 홍삼 및 흑삼 제조 시 온도, 압력, 시간 등의 조절이 불규칙하여 성분의 함량과 색도 및 향미 등의 문제가 발생하고 있다. 따라서, 인삼을 가공 처리하여 진세노사이드를 증가시키는 과정에서 인체 무해하며 진세노사이드의 소실을 방지하기 위한 온도, 압력, 시간 등의 표준화된 가공공정은 매우 중요하다.Red ginseng and black ginseng are typically used as processed ginseng to increase ginsenoside by processing ginseng. However, red ginseng and black ginseng are steamed and dried, resulting in a rapid decrease in weight and the production of benzopyrene, a carcinogen, and complex. It has disadvantages such as an increase in manufacturing cost due to the manufacturing process, and the temperature, pressure, time, etc., are irregularly controlled during the manufacture of red ginseng and black ginseng, causing problems such as the content of ingredients, color, and flavor. Therefore, in the process of increasing ginsenoside by processing ginseng, it is harmless to the human body, and standardized processing processes such as temperature, pressure, and time are very important to prevent loss of ginsenoside.

그러나 현재까지 인삼 및 가공삼에서 진세노사이드의 성분을 증가시키기 위한 열처리 방법, 발효를 위한 미생물 및 그 이용 방법, 온도, 압력, 시간 등의 표준화 등 효율적인 제조방법, 특히, 기억력 증강 및 NMDA로 유발된 신경독으로부터 신경세포 보호효과가 우수하므로 뇌기능, 학습능력 또는 인지기능 개선효과가 우수한 진세노사이드 Rg3, Rg5, Rk1의 함량을 인삼으로부터 증가시키는 제조방법이 구체적인 실험이나 연구를 통한 결과도 보고되지 않았다. However, until now, efficient manufacturing methods such as heat treatment methods to increase the components of ginsenosides in ginseng and processed ginseng, microorganisms for fermentation and methods of use thereof, standardization of temperature, pressure, time, etc., in particular, increase memory and cause NMDA. Since it has excellent neurotoxin protection from neurotoxins, a manufacturing method that increases the content of ginsenosides Rg3, Rg5, and Rk1, which are excellent in improving brain function, learning ability or cognitive function, from ginseng has not been reported through specific experiments or studies. Did.

1. 대한민국 공개특허 10-2013-00626281. Republic of Korea Patent Publication 10-2013-0062628 2. 대한민국 등록특허 10-06650872. Korean Patent Registration 10-0665087

이러한 배경하에서, 본 발명이 이루고자 하는 기술적 과제는 종래의 홍삼 또는 흑삼의 제조 방법 및 제조된 홍삼 또는 흑삼을 미생물을 이용하여 발효하는 방법에 의하지 않고 기억력 증강 및 NMDA로 유발된 신경독으로부터 신경세포 보호효과가 우수하므로 뇌기능, 학습능력 또는 인지기능 개선효과가 우수한 진세노사이드 Rg3, Rg5, Rk1의 함량을 인삼으로부터 증가시키는 제조방법을 제공하는 것이다.Under this background, the technical task to be achieved by the present invention is to enhance memory and protect nerve cells from neurotoxins caused by NMDA, without using a conventional method for producing red or black ginseng and fermenting the prepared red or black ginseng using microorganisms. It is to provide a manufacturing method that increases the content of ginsenosides Rg3, Rg5, and Rk1, which are excellent in improving brain function, learning ability or cognitive function, from ginseng.

상기 기술적 과제를 달성하기 위하여, 본 발명은In order to achieve the above technical problem, the present invention

(a) 수삼을 분쇄하여 수삼 분쇄물을 얻는 단계;(a) pulverizing fresh ginseng to obtain a pulverized fresh ginseng;

(b) 상기 수삼 분쇄물을 마이크로웨이브 전용용기에 넣고 용기의 뚜껑을 닫은 후에 마이크로웨이브를 이용하여 열처리하는 단계;(b) placing the pulverized fresh ginseng in a microwave-only container, closing the lid of the container, and performing heat treatment using a microwave;

(c) 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배지에 접종한 다음 배양한 후 멸균 처리하여 상기 (b) 단계를 완료한 수삼을 처리하기 위한 처리액을 준비하는 단계; 및(c) Lactobacillus inoculated with Bacillus Francisco taryum (Lactobacillus plantarum) MH16 in the medium, and then preparing a processing liquid for processing by a sterilization treatment and incubated complete the step (b) the fresh ginseng; And

(d) 상기 (c) 단계에서 준비한 처리액에 상기 (b) 단계를 통하여 열처리한 수삼을 넣고 숙성하는 단계를 포함하는 것으로 특징으로 하는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법을 제공한다.(d) ginseno having excellent brain function and cognitive function improvement effect using ginseng, comprising the step of aging the heat-treated fresh ginseng through the (b) step to the treatment solution prepared in step (c). It provides a method for preparing a composition rich in side Rg3, Rg5, and Rk1.

상술한 바와 같은 본 발명에 따른 제조방법에 있어서, 상기 (b) 단계의 마이크로웨이브를 이용한 열처리는 500~5.000MHz의 주파수 마이크로웨이브에서 0.5 내지 5시간 동안 처리하는 것일 수 있다.In the manufacturing method according to the present invention as described above, the heat treatment using a microwave in step (b) may be performed in a microwave at a frequency of 500 to 5.000 MHz for 0.5 to 5 hours.

상술한 바와 같은 본 발명에 따른 제조방법에 있어서, 상기 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배양하기 위한 (c) 단계의 배지는 In the production process according to the invention as described above, the Lactobacillus Francisco taryum medium of step (c) to a culture (Lactobacillus plantarum) has MH16

0.5 내지 1.5 (w/v)% peptone, 0.5 to 1.5 (w/v)% peptone,

0.5 내지 1.5 (w/v)% beef extract,0.5 to 1.5 (w/v)% beef extract,

0.5 내지 1.5 (w/v)% dipotassium hydrogen phosphate, 0.5 to 1.5 (w/v)% dipotassium hydrogen phosphate,

0.5 내지 1.5 (w/v)% triammonium citrate,0.5 to 1.5 (w/v)% triammonium citrate,

0.5 내지 1.5 (w/v)% magnesium sulfate heptahydrate,0.5 to 1.5 (w/v)% magnesium sulfate heptahydrate,

7.0 내지 20.0 (w/v)% 무즙,7.0-20.0 (w/v)% juice-free,

7.0 내지 20.0 (w/v)% 배즙,7.0-20.0 (w/v)% pear juice,

잔부 (w/v)%의 증류수Balance (w/v)% of distilled water

를 포함하는 것일 수 있다.It may be to include.

상술한 바와 같은 본 발명에 따른 제조방법에 있어서, 상기 (c) 단계의 배양은 상기 배지 100중량부에 대하여 1.0 내지 10.0중량부로 상기 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 접종한 다음 25 내지 45℃에서 10 내지 72시간 동안 이루어지는 것일 수 있다.Inoculated with a manufacturing method according to the invention, the step (c) culturing the Lactobacillus Francisco taryum (Lactobacillus plantarum) 1.0 part to 10.0 parts by weight per 100 parts by weight of the medium of MH16 as described above, and then 25 to 45 It may be made for 10 to 72 hours at ℃.

상술한 바와 같은 본 발명에 따른 제조방법에 있어서, 상기 (d) 단계의 숙성은 4 내지 30℃에서 10 내지 72시간 동안 이루어지는 것일 수 있다.In the manufacturing method according to the present invention as described above, the aging in step (d) may be performed at 4 to 30° C. for 10 to 72 hours.

본 발명은 다른 기술적 과제를 달성하기 위하여, The present invention in order to achieve another technical problem,

상술한 바와 같은 제조방법에 의해 제조되어 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물을 유효성분으로 포함하는 것을 특징으로 하는 뇌기능 및 인지기능 개선 효과가 우수한 약학적 조성물 또는 건강식품 조성물을 제공한다.It provides a pharmaceutical composition or a health food composition excellent in improving brain function and cognitive function, characterized in that it contains a composition rich in Rg3, Rg5, and Rk1 as an active ingredient prepared by the above-described manufacturing method. .

본 발명은 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1이 현저하게 증가되는 제조방법으로서, 본 발명의 제조방법은 종래의 홍삼 내지 흑삼을 제조하는 공정에 비하여 열처리 과정 및 미생물을 이용하여 인삼을 직접 발효하는 숙련된 공정이 아닌 배지에 효소 생성 능력이 우수하고 유기산을 풍부하게 생성하는 미생물을 배양한 후에 이 배양액으로 열처리한 인삼을 처리하는 숙성 공정을 통하여 은 간소하고 표준화되어 효율적이고 품질 관리에 용이하다,The present invention is a manufacturing method in which ginsenosides Rg3, Rg5, and Rk1, which are excellent in improving brain function and cognitive function, are significantly increased.The manufacturing method of the present invention is a heat treatment process and microorganisms compared to the conventional red ginseng to black ginseng manufacturing process. It is not a skilled process of directly fermenting ginseng using using, but through the aging process of treating ginseng heat-treated with this culture after cultivating microorganisms that have excellent enzyme production ability and rich organic acid in a medium. Efficient and easy to manage quality,

이하. 본 발명이 실시하기 위한 구체적인 내용을 상세하게 설명한다.Below. The specific details for carrying out the present invention will be described in detail.

본 발명은 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1의 함량을 인삼으로부터 증가시키는 제조방법으로서,The present invention is a manufacturing method for increasing the content of ginsenosides Rg3, Rg5, Rk1 excellent in brain function and cognitive function improvement from ginseng,

(a) 수삼을 분쇄하여 수삼 분쇄물을 얻는 단계;(a) pulverizing fresh ginseng to obtain a pulverized fresh ginseng;

(b) 상기 수삼 분쇄물을 마이크로웨이브 전용용기에 넣고 용기의 뚜껑을 닫은 후에 마이크로웨이브를 이용하여 열처리하는 단계;(b) placing the pulverized fresh ginseng in a microwave-only container, closing the lid of the container, and performing heat treatment using a microwave;

(c) 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배지에 접종한 다음 배양한 후 멸균 처리하여 상기 (b) 단계를 완료한 수삼을 처리하기 위한 처리액을 준비하는 단계; 및(c) Lactobacillus inoculated with Bacillus Francisco taryum (Lactobacillus plantarum) MH16 in the medium, and then preparing a processing liquid for processing by a sterilization treatment and incubated complete the step (b) the fresh ginseng; And

(d) 상기 (c) 단계에서 준비한 처리액에 상기 (b) 단계를 통하여 열처리한 수삼을 넣고 숙성하는 단계를 포함한다.(d) adding fresh ginseng heat-treated through step (b) to the treatment solution prepared in step (c) and aging.

상술한 본 발명에서 상기 수삼은 수확된 인삼을 건조하지 않은 것을 의미하는 것으로서, 보관을 위하여 냉동한 경우 이를 해동하여 사용하여도 되고 냉동된 상태에서 그냥 사용하여도 무방하며, 본 발명에서의 인삼은 홍삼 내지 흑삼을 제조하기 위하여 수확되는 인삼이라면 특별한 제한없이 사용가능하다.In the present invention described above, the fresh ginseng means that the harvested ginseng is not dried, and when frozen for storage, it may be thawed and used, or it may be used in a frozen state. Any ginseng harvested to produce red ginseng or black ginseng can be used without special restrictions.

본 발명은 상기 수삼을 분쇄하여 수삼 분쇄물을 얻는데, 이때 분쇄 방법은 특별하게 제한이 없으며, 분쇄물 크기 역시 특별한 제한이 없으나 미세할수록 후술하는 열처리 효과가 상승될 수 있다.In the present invention, the fresh ginseng is pulverized to obtain a fresh ginseng pulverized product. In this case, the pulverization method is not particularly limited, and the size of the pulverized product is also not particularly limited, but the finer the heat treatment effect described later may be increased.

또한, 본 발명은 수삼을 분쇄하는 동안에 별도에 물을 더 첨가하지 않고 수삼을 그대로 분쇄하는 것이 바람직하며, 분쇄하는 동안에 발생하는 수분을 후술하는 열처리에 과정에 그대로 이용이 된다.In addition, in the present invention, it is preferable to pulverize the ginseng as it is without adding additional water while pulverizing the ginseng, and the moisture generated during pulverization is used as it is in the heat treatment to be described later.

이어서, 상기 제조한 수분을 함유하고 있는 수삼 분쇄물을 마이크로웨이브 전용 용기에 넣고 뚜껑을 덮은 다음 마이크로웨이브를 이용하여 열처리한다.Next, the prepared pulverized fresh ginseng containing moisture is placed in a microwave-only container, covered with a lid, and then heat-treated using microwaves.

본 발명에서 용기의 뚜껑을 덮고 하는 것은 열처리 과정에서 발생하는 증기가 날아가지 않고 뚜껑에서 다시 수분을 되어 용기 하부로 흘러내려 별도의 수분 보충업시 수삼이 증숙되는 효과를 거두기 위함이다. Covering the lid of the container in the present invention is to achieve the effect of steaming the fresh ginseng during a separate water replenishment business as the vapor generated in the heat treatment process does not fly away, and the water is rehydrated from the lid and flows down to the bottom of the container.

이와 같은 본 발명에 따른 마이크로웨이브 열처리는 통하는 경우 종래의 홍삼이나 흑삼을 제조하기 위하여 증기로 찌는 공정에서 외부에서 보충되는 증기에 의해 인삼에서 열수 추출이 이루어지는 과정을 거치게 되어 유효성분이 손실되고 건조 공정을 거치기 때문에 이를 다시 사용할 수 있는 방법이 없으나 본 발명에서는 별도의 수분 내지 증기의 공급이 없이 수삼이 가지고 있는 수분만을 이용하는 것이어서 유효성분 손실이 없으며 또한 본 발명은 후술하는 숙성 과정에 열처리 과정을 완료한 후에 남아 있는 수분을 그대로 이용하게 되어 손실의 문제가 발생하지 않는다.When the microwave heat treatment according to the present invention passes through, the process of extracting hot water from the ginseng by steam supplemented from the outside in the process of steaming in order to manufacture red ginseng or black ginseng in the related art is performed, so that active ingredients are lost and the drying process is performed. There is no method to use it again because it is passed through, but in the present invention, since only the moisture contained in the fresh ginseng is used without supply of additional moisture or steam, there is no loss of active ingredients. In addition, the present invention is after completing the heat treatment process in the aging process described later. Since the remaining moisture is used as it is, there is no problem of loss.

상술한 바와 같은 마이크로웨이브 열처리는 본 발명이 속하는 기술 분야에 널리 알려진 것이라면 특별한 제한이 없으나, 500~5.000MHz의 주파수 마이크로웨이브에서 0.5 내지 5시간 동안 처리하는 것일 수 있으며, 구체적인 선택은 수삼 상태, 처리하여야 하는 수삼의 중량을 고려하여 적절하게 이루어질 수 있다.The microwave heat treatment as described above is not particularly limited as long as it is widely known in the technical field to which the present invention belongs, but may be treated for 0.5 to 5 hours in a microwave at a frequency of 500 to 5.000 MHz, and the specific selection is fresh ginseng state, treatment It can be done appropriately in consideration of the weight of fresh ginseng to be taken.

다음으로, 숙성을 위한 처리액을 제조하여 이 처리액을 이용하여 열처리한 수삼을 숙성하면 본 발명에 따른 제조방법은 완료된다.Next, when a treatment liquid for aging is prepared and the heat-treated fresh ginseng is aged using this treatment liquid, the manufacturing method according to the present invention is completed.

상기 처리액 제조는락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배지에 접종한 다음 배양한 후 멸균 처리하여 이루어지며, 숙성은 상기 준비한 처리액에 상기 열처리는 마친 수삼 및 그 용기 내 수분을 그대로 넣고 일정 조건에 보관하게 되며 숙성을 위한 용기는 특별한 제한이 없으나 옹기와 같은 쉼 쉬는 용기가 바람직하다.The treatment fluid formulation is Lactobacillus Francisco taryum made by the MH16 (Lactobacillus plantarum) process, and then cultured after sterilization inoculated to the medium, fermentation is put into the water within the heat treatment is finished ginseng and its container in the prepared treatment solution as certain It is stored under conditions, and there is no particular limitation on the container for aging, but a container for rest such as pottery is preferable.

상술한 바와 같은 본 발명에 따른 제조방법에 있어서, 상기 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배양하기 위한 (c) 단계의 배지는 MRS 배지와 같이 락토바실러스의 배양을 위하여 일반적으로 사용되는 배지일 수 있으나 본 발명에서는 아래와 같은 조성을 가진 배지를 이용하는 것이 바림직하며, 상기 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16 균주의 선정 과정 및 배지 조성에 대해서는 후술하는 실시예를 통하여 구체적으로 설명하기 로 한다.In the production process according to the invention as described above, the Lactobacillus Francisco taryum (Lactobacillus plantarum) medium of the (c) step of culturing the MH16 is job medium commonly used for culture of the Lactobacillus bacteria, such as MRS medium can, but the present invention will be described in detail through the embodiments to be described later in the selection process and the medium composition of the gradation is straight, and the Lactobacillus Francisco taryum (Lactobacillus plantarum) MH16 strain using a medium having a composition as shown below.

본 발명에서 사용되는 배지는 1.0 (w/v)% peptone, 1.0 (w/v)% beef extract, 0.4 (w/v)% yeast extract, 2.0 (w/v)% glucose, 0.5 (w/v)% sodium acetate trihydrate, 0.1 (w/v)% polysorbate 80 (also known as Tween 80), 0.2 (w/v)% dipotassium hydrogen phosphate, 0.2 (w/v)% triammonium citrate, 0.02 (w/v)% magnesium sulfate heptahydrate, 0.005 (w/v)% manganese sulfate tetrahydrate의 조성을 가지는 MRS 배지를 변경하여 The medium used in the present invention is 1.0 (w/v)% peptone, 1.0 (w/v)% beef extract, 0.4 (w/v)% yeast extract, 2.0 (w/v)% glucose, 0.5 (w/v) )% sodium acetate trihydrate, 0.1 (w/v)% polysorbate 80 (also known as Tween 80), 0.2 (w/v)% dipotassium hydrogen phosphate, 0.2 (w/v)% triammonium citrate, 0.02 (w/v) % magnesium sulfate heptahydrate, 0.005 (w/v)% manganese sulfate tetrahydrate by changing the MRS medium

0.5 내지 1.5 (w/v)% peptone, 0.5 to 1.5 (w/v)% peptone,

0.5 내지 1.5 (w/v)% beef extract,0.5 to 1.5 (w/v)% beef extract,

0.5 내지 1.5 (w/v)% dipotassium hydrogen phosphate, 0.5 to 1.5 (w/v)% dipotassium hydrogen phosphate,

0.5 내지 1.5 (w/v)% triammonium citrate,0.5 to 1.5 (w/v)% triammonium citrate,

0.5 내지 1.5 (w/v)% magnesium sulfate heptahydrate,0.5 to 1.5 (w/v)% magnesium sulfate heptahydrate,

7.0 내지 20.0 (w/v)% 무즙,7.0-20.0 (w/v)% juice-free,

7.0 내지 20.0 (w/v)% 배즙,7.0-20.0 (w/v)% pear juice,

잔부 (w/v)%의 증류수Balance (w/v)% of distilled water

를 포함하는 것이 바람직하다.It is preferable to include.

본 발명의 상기 (c) 단계의 배양은 특별한 제한은 없으나, 상술 배지 100중량부에 대하여 1.0 내지 10.0중량부로 상기 락토바실러스 프란타륨(Lactobacillus plantarum) MH16을 접종한 다음 25 내지 45℃에서 10 내지 72시간 동안 이루어지는 것일 수 있다.The cultivation of the step (c) of the present invention is not particularly limited, but after inoculating the Lactobacillus plantarum MH16 at 1.0 to 10.0 parts by weight based on 100 parts by weight of the medium, 10 to 72 at 25 to 45°C. It can be done over time.

이와 같은 배양이 완료된 후에는 멸균처리하여 숙성을 위한 처리액으로 사용하게 되는데, 멸균처리는 가열을 하는 등 본 발명이 속하는 기술분야에 알려진 것이라면 특별한 제한없이 가능하나, 바람직게는 가열에 의한 변화를 최소로 하기 위하여 균을 제거하여 무균 상태로 만들 수 있는 여과 방법을 이용하는 것이 바람직하며, 멤브레인 필터를 이용하여 여과를 통하여 멸균된 액을 만드는 것이 통상적인 방법이라 할 수 있다.After such cultivation is completed, it is sterilized to be used as a treatment solution for aging. The sterilization treatment is possible without particular limitation, as long as it is known in the art to which the present invention belongs, such as heating. In order to minimize it, it is preferable to use a filtration method capable of removing germs and making them sterile, and it can be said that a conventional method is to prepare a sterilized liquid through filtration using a membrane filter.

마지막 단계인 본 발명의 숙성은 상기 준비한 처리액에 열처리가 완료되는 수삼을 용기 내의 수분과 함께 넣고 일정 조건에 방치하는 것으로서 통상적으로 발효액 및 효소액을 제조하는 과정에서의 숙성이라면 특별한 제한없이 이용이 가능하며, 본 발명에서는 상기 (d) 단계의 숙성은 4 내지 30℃에서 10 내지 72시간 동안 이루어지는 것일 수 있다.The final step, the aging of the present invention, is to put fresh ginseng that has been heat-treated in the prepared treatment liquid together with moisture in a container and leave it to stand under certain conditions.If it is aging in the process of preparing fermentation liquid and enzyme liquid, it can be used without particular limitation. And, in the present invention, the aging of step (d) may be performed at 4 to 30° C. for 10 to 72 hours.

상술한 바와 같은 본 발명은 마이크로웨이브를 이용하여 유효성분의 손실 없이 열처리를 할 수 있으며, 새롭게 구성한 전용 배지를 이용하여 효소와 유기산 생성 능력이 뛰어난 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16를 배양하여 효소 활성이 매우 뛰어나고 유기산이 풍부한 배양액을 제조할 수 있어 이를 이용하여 숙성하므로서 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물을 제조할 수 있다.The present invention can be heat-treated by using a microwave without any loss of the active ingredient, the newly configured using a dedicated medium enzymes and organic acid producing ability is excellent Lactobacillus Francisco taryum (Lactobacillus plantarum) enzyme by culturing the MH16 as described above Since it has excellent activity and can prepare a culture medium rich in organic acids, it is possible to prepare a composition rich in Rg3, Rg5, and Rk1 by aging using this.

따라서 본 발명은 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1이 현저하게 증가되는 제조방법으로서, 본 발명의 제조방법은 종래의 홍삼 내지 흑삼을 제조하는 공정에 비하여 열처리 과정 및 미생물을 이용하여 인삼을 직접 발효하는 숙련된 공정이 아닌 배지에 효소 생성 능력이 우수하고 유기산을 풍부하게 생성하는 미생물을 배양한 후에 이 배양액으로 열처리한 인삼을 처리하는 숙성 공정을 통하여 은 간소하고 표준화되어 효율적이고 품질 관리에 용이하다,Accordingly, the present invention is a manufacturing method in which ginsenosides Rg3, Rg5, and Rk1, which are excellent in improving brain function and cognitive function, are significantly increased, and the manufacturing method of the present invention comprises a heat treatment process and a heat treatment process compared to the conventional process of manufacturing red ginseng to black ginseng. Rather than a skilled process of directly fermenting ginseng using microorganisms, it is simple and standardized through the aging process of treating ginseng heat-treated with this culture after cultivating microorganisms that have excellent enzyme-producing ability and rich organic acids in a medium. Is efficient and easy for quality control.

이하 실시예 및 시험예를 통하여 본 발명을 상세하게 설명하기로 하며, 후술하는 실시예에 의해 본 발명이 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through Examples and Test Examples, and the present invention is not limited by Examples to be described later.

실시예Example 1: 균주 선발 1: strain selection

1. 균주 배양 및 보관1. Strain culture and storage

실험에 사용된 유산균주는 전통발효시료에서 분리한 유산균과 비교 균주로 발효산업미생물진흥원, 한국미생물보존센터(KCCM), 한국생명공학연구원 생물자원센터(KCTC) 등에서 분양받은 균주를 사용하였다. The lactic acid strain used in the experiment was a strain obtained from the Fermentation Industry Microbiology Promotion Agency, the Korea Microbiological Conservation Center (KCCM), and the Korea Research Institute of Bioscience and Biotechnology Biological Resource Center (KCTC) as a comparative strain with the lactic acid bacteria isolated from the traditional fermentation sample.

확보된 균주는 MRS 액체배지에 1%씩 접종하여 37℃, 48시간 배양하여 사용하였고, 사용이 종료된 후에는 60% 글리세롤 용액과 함께 -70℃ deep freezer에 보관하였다.The obtained strains were inoculated in MRS liquid medium by 1% and cultured for 48 hours at 37°C, and after the end of use, they were stored in a deep freezer at -70°C with 60% glycerol solution.

2. 효소활성 평가2. Evaluation of enzyme activity

효소활성을 평가하여 최종균주를 선발하기 위해 하기와 같은 방법을 통해 세포 외 효소활성, API ZYM을 이용한 효소활성을 평가하였다.In order to evaluate the enzyme activity and select the final strain, extracellular enzyme activity and enzyme activity using API ZYM were evaluated through the following method.

먼저, 1차로 선별된 1차 균주의 세포외 효소 활성 측정은 프로테아제와 베타글루코시데이즈에 대하여 조사하였고, 1% skim milk(Difco), 0.5% esculin(sigma)를 각각의 기질로 하여 well diffusion 방법을 이용하여 측정하였다.First, the measurement of the extracellular enzyme activity of the primary strain selected first was investigated for protease and beta glucosidase, and a well diffusion method using 1% skim milk (Difco) and 0.5% esculin (sigma) as respective substrates. It was measured using.

또한, 1차 균주의 효소 활성을 조사하기 위해 API ZYM kit(bioMerieux Co., Marcy-I'Etoile, France)를 사용하여 alkaline phosphatase 외 18가지 효소 활성을 검사하였다. 균주를 MRS 고체배지에서 배양하여 균체를 회수하고 멸균수에 3회 세척한 후 멸균수에 현탁하여 시료를 준비하였다. 현탁액 500 ul를 5 mL suspension medium에 풀어준 후 5~6 Mcfarland(bioMerieux Co.)로 탁도를 조정하였다. 탁도를 조정한 현택액을 ZYM kit의 각 큐플에 접종하여 37℃에서 4시간 배양한 후 표현 활성 증가와 용해를 도와주는 ZYM A, B 시약을 각각의 큐플에 한 방울씩 떨어뜨려 5분간 반응 후 색깔의 변화를 관찰하여 효소 활성 정도를 조사하였다. 이때, 색의 변화 정도에 따라 0~5까지의 값으로 표시하였으며, 0은 음성반응, 5 (≥40 nmoles)는 최대 강도의 반응이고 4~1은 각각 30, 20, 10, 5 nmoles의 중간 값을 나타내며 3 이상일 경우 양성으로 판정하였다.In addition, 18 enzyme activities other than alkaline phosphatase were tested using API ZYM kit (bioMerieux Co., Marcy-I'Etoile, France) to investigate the enzyme activity of the primary strain. The strain was cultured in MRS solid medium to recover the cells, washed three times in sterile water, and then suspended in sterile water to prepare a sample. After dissolving 500 ul of the suspension in a 5 mL suspension medium, turbidity was adjusted with 5-6 Mcfarland (bioMerieux Co.). After inoculating the turbidity-adjusted suspension solution into each cuple of the ZYM kit and incubating for 4 hours at 37°C, drop one drop of ZYM A and B reagents to help increase expression activity and dissolution into each cuple and react for 5 minutes. The degree of enzyme activity was investigated by observing the change in color. At this time, according to the degree of color change, the values ranged from 0 to 5, where 0 is a negative response, 5 (≥40 nmoles) is the maximum intensity response, and 4-1 is the middle of 30, 20, 10, and 5 nmoles, respectively. A value of 3 or more was determined as positive.

비교균주와 1차 균주의 세포 외 효소활성 및 ZYM kit 결과는 하기 표 1 및 표 2와 같다.The extracellular enzyme activity and ZYM kit results of the comparative strain and the primary strain are shown in Tables 1 and 2 below.

Figure pat00001
Figure pat00001

Figure pat00002
Figure pat00002

먼저, 표 1을 보면 알 수 있듯이, 비교균주인 KCTC 3035의 반응은 확인하기 어려웠고, KCCM 12116은 활성이 나타나긴 하였으나, MH16의 활성이 가장 뛰어난 것을 확인하였으며, SRCM 102226은 반응이 나타나지 않는 것을 확인할 수 있었다.First, as can be seen from Table 1, it was difficult to confirm the reaction of the comparative strain KCTC 3035, and KCCM 12116 showed the activity, but it was confirmed that the activity of MH16 was the most excellent, and SRCM 102226 was confirmed that the reaction did not appear. Could

또한, 표 2를 보면 알 수 있듯이, ZYM kit를 이용해 추가 효소활성을 검토한 결과에서도 비교 균주에 비해 MH16의 효소활성이 현저하게 높은 것을 확인할 수 있었다.In addition, as can be seen from Table 2, it was confirmed that the enzyme activity of MH16 was remarkably higher than that of the comparative strain in the results of examining the additional enzyme activity using the ZYM kit.

구체적으로, MH16는 ZYM kit를 통해 β-glucosidase 외에도 11종의 효소활성이 더 있는 것으로 관찰되었다. Specifically, it was observed that MH16 has 11 more enzyme activities in addition to β-glucosidase through the ZYM kit.

지방 분해에 관여하는 Esterase, Esterase lipase와 펩타이드 가수분해 효소인 Leucine arylamidase, Valine arylamidase, Cystine arylamidase 등에서 5~30 nmol의 활성을 나타내었고, 유당 분해에 관여하는 β-galactosidase는 가장 낮은 10 nmol의 활성을 나타냈으나, ginsenoside 전환에 필요한 β-glucosidase의 활성은 30 nmol로 확인되었다.Esterase, esterase lipase, and peptide hydrolyzing enzymes such as Leucine arylamidase, Valine arylamidase, and Cystine arylamidase, which are involved in lipolysis, showed 5~30 nmol activity. However, the activity of β-glucosidase required for ginsenoside conversion was confirmed to be 30 nmol.

이에, 유산균주 중에서 효소활성이 우수한 Lactobacillus plantarum MH16을 최종균주로 선발하였다.Accordingly, Lactobacillus plantarum MH16, which has excellent enzyme activity, was selected as the final strain.

3. 유기산 함량 평가3. Evaluation of organic acid content

배양액의 유기산 함량을 평가하여 최종 균주를 선발하기 위해 하기와 같은 방법을 평가하였다.The following method was evaluated in order to select the final strain by evaluating the organic acid content of the culture solution.

유기산은 High Perfomrnace Liquid Chromatography (HPLC)를 이용하여 실시하였고, 시료 5g에 증류수로 50 mL로 맞추고 37℃, 3시간 교반한 후, 0.45㎛ membrane filter에 통과시킨 후 시료로 사용하였다. The organic acid was carried out using High Perfomrnace Liquid Chromatography (HPLC), adjusted to 50 mL of distilled water in 5 g of sample, stirred at 37° C. for 3 hours, passed through a 0.45 μm membrane filter, and used as a sample.

유리산 분석 조건은 하기 표 3과 같이 설정하여 진행하였다.Free acid analysis conditions were performed by setting as shown in Table 3 below.

Figure pat00003
Figure pat00003

각 균주에 대하여 총 유기산 함량을 측정하여 그 결과를 하기 표 4에 나타냈다.The total organic acid content was measured for each strain, and the results are shown in Table 4 below.

Figure pat00004
Figure pat00004

상기 표 4에서 알 수 있듯이 유산균주 중에서 유기산 함량이 많은 Lactobacillus plantarum MH16을 최종 균주로 선발하여, 상기 최종 균주로 선정된 유산균인 Lactobacillus plantarum MH16이다.As can be seen in Table 4, Lactobacillus plantarum MH16, which has a high organic acid content, was selected as the final strain among the lactic acid strains, and Lactobacillus plantarum MH16, which was selected as the final strain.

균주의 동정 결과는 하기와 같다.The result of identification of the strain is as follows.

Figure pat00005
Figure pat00005

실시예Example 2. 배지 평가 2. Badge evaluation

락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배양하기 위한 (c) 단계의 배지는 Lactobacillus Francisco taryum medium of step (c) to a culture (Lactobacillus plantarum) has MH16

0.5 내지 1.5 (w/v)% peptone, 0.5 to 1.5 (w/v)% peptone,

0.5 내지 1.5 (w/v)% beef extract,0.5 to 1.5 (w/v)% beef extract,

0.5 내지 1.5 (w/v)% dipotassium hydrogen phosphate, 0.5 to 1.5 (w/v)% dipotassium hydrogen phosphate,

0.5 내지 1.5 (w/v)% triammonium citrate,0.5 to 1.5 (w/v)% triammonium citrate,

0.5 내지 1.5 (w/v)% magnesium sulfate heptahydrate,0.5 to 1.5 (w/v)% magnesium sulfate heptahydrate,

7.0 내지 20.0 (w/v)% 무즙,7.0-20.0 (w/v)% juice-free,

7.0 내지 20.0 (w/v)% 배즙,7.0-20.0 (w/v)% pear juice,

잔부 (w/v)%의 증류수Balance (w/v)% of distilled water

를 포함하는 것을 특징으로 하는데 이와 같은 배지의 효과를 평가 위하여 MRS 배지에서 동일한 조건으로 배양하여 배양액의 효소 활성과 유기산 함량을 측정하여 본 발명에 따른 배지의 효과를 평가하였다.In order to evaluate the effect of such a medium, it was cultured in MRS medium under the same conditions, and the enzyme activity and organic acid content of the culture medium were measured to evaluate the effect of the medium according to the present invention.

본 발명에 따른 배지는 1.0 (w/v)% peptone, 1.0 (w/v)% beef extract, 1.0 (w/v)% dipotassium hydrogen phosphate, 1.0 (w/v)% triammonium citrate, 1.0 (w/v)% magnesium sulfate heptahydrate, 15 (w/v)% 무즙, 15 (w/v)% 배즙 및 잔부 (w/v)%의 증류수로 구성이 되었다.The medium according to the present invention is 1.0 (w/v)% peptone, 1.0 (w/v)% beef extract, 1.0 (w/v)% dipotassium hydrogen phosphate, 1.0 (w/v)% triammonium citrate, 1.0 (w/ v)% magnesium sulfate heptahydrate, 15 (w/v)% radish juice, 15 (w/v)% pear juice, and the balance (w/v)% distilled water.

배양은 배지 100중량부에 대하여 1중량부씩 접종하여 37℃, 48시간 배양하였으며, 배양을 완료한 후 멤브레인 필터를 이용하여 배양균주 및 고형물을 제거하는 여과를 실시한 후 여액을 이용하여 효소 활성과 유기산 총 함량을 측정하였으며, 측정방법은 실시예 1에서 동일하며, 그 결과는 하기 표 5에 나타냈다.Culture was carried out at 37°C for 48 hours by inoculating 1 part by weight with respect to 100 parts by weight of the medium. After the culture was completed, filtration was performed to remove culture strains and solids using a membrane filter. The total content was measured, and the measurement method was the same in Example 1, and the results are shown in Table 5 below.

Figure pat00006
Figure pat00006

상기 표 5에서 보는 바와 같은 본 발명에 따른 배지에 배양하는 경우 배양액의 효소 활성 및 총 유기산 함량이 현저하게 증가되는 것을 알 수 있었다.When cultured in the medium according to the present invention as shown in Table 5, it was found that the enzyme activity and the total organic acid content of the culture medium were significantly increased.

실시예Example 3: 본 발명에 따른 조성물 제조 및 3: Preparation of the composition according to the invention and Rg3Rg3 , , Rg5Rg5 , , Rk1의Rk1 함량 비교 시험 Content comparison test

1. 본 발명에 따른 조성물 제조1. Preparation of the composition according to the invention

진안에서 구입한 4년근 수삼 1kg을 분쇄기를 이용한 분쇄한 다음 이 분쇄물을 마이크로웨이브 전용 용기에 넣고 뚜껑을 닫은 후에 2.000MHz의 주파수 마이크로웨이브에서 2.5시간 동안 처리한 후에 냉각시켰다.1 kg of 4-year-old fresh ginseng purchased from Jinan was pulverized using a grinder, and the pulverized product was put in a microwave-only container, closed, and then cooled in a 2.000 MHz frequency microwave for 2.5 hours.

이어서, 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16의 배양액을 실시예 2에서 제조한 배양액을 이용하였으며, 상기 열처리 후 냉각된 수삼 분쇄물을 넣고 10℃에서 30시간 동안 숙성하여 본 발명에 따른 조성물을 제조하였다.Then preparing a composition according to the present invention Lactobacillus bacteria Francisco taryum (Lactobacillus plantarum) was used for a culture medium to prepare a culture solution of the MH16 in the second embodiment, placed after the heat treatment the cooling ginseng pulverized by aging at 10 ℃ for 30 hours, I did.

2. 2. Rg3Rg3 , , Rg5Rg5 , , Rk1의Rk1 함량 비교 시험 Content comparison test

상기 제조한 본 발명에 다른 조성물에 대항 Rg3, Rg5, Rk1의 함량 시험을 실시하였으며, 그 비교예로서 시판되는 홍삼 농축액, 흑삼 농축액, 홍삼 발효 농축액, 흑삼 발효 농축액을 구입하여 Rg3, Rg5, Rk1의 함량을 비교하였다.The content of Rg3, Rg5, and Rk1 was tested against the other compositions of the present invention. The contents were compared.

함량 시험은 HPLC를 이용하였으며, 함량 분석 조건은 아래와 같으며, 그 결과는 표 6에 나타냈다.The content test was performed using HPLC, the content analysis conditions were as follows, and the results are shown in Table 6.

HPLC : YL9100 HPLC system (영린, Korea)HPLC: YL9100 HPLC system (Youngrin, Korea)

Detector : ELSD ZAM 3000 (Schambeck SFD GmbH, Germany)Detector: ELSD ZAM 3000 (Schambeck SFD GmbH, Germany)

Column : Luna C18 5 um, 46 x 150 mm (Phenomenex, USA)Column: Luna C18 5 um, 46 x 150 mm (Phenomenex, USA)

Solvent : A: Acetonitril : Water : 5% Acetic acid in water = 15 : 80 : 5(v/v), B : Acetonitril :Water = 80 : 20(v/v)Solvent: A: Acetonitril: Water: 5% Acetic acid in water = 15: 80: 5(v/v), B: Acetonitril :Water = 80: 20(v/v)

Flow rate: 10 mL/minFlow rate: 10 mL/min

0분(min) A:B = 100:0, 6분 A:B = 70:30, 18분 A:B = 50:50, 30분 A:B = 0:[0087] 100, 37분 A:B = 0:1000min (min) A:B = 100:0, 6min A:B = 70:30, 18min A:B = 50:50, 30min A:B = 0:[0087] 100, 37min A: B = 0:100

Figure pat00007
Figure pat00007

상기 표 6에서 알 수 있듯이, 본 발명에 따른 조성물에서 Rg3, Rg5, Rk1의 함량이 현저하게 증가함을 확인할 수 있었다.As can be seen from Table 6, it was confirmed that the contents of Rg3, Rg5, and Rk1 were significantly increased in the composition according to the present invention.

Claims (7)

(a) 수삼을 분쇄하여 수삼 분쇄물을 얻는 단계;
(b) 상기 수삼 분쇄물을 마이크로웨이브 전용용기에 넣고 용기의 뚜껑을 닫은 후에 마이크로웨이브를 이용하여 열처리하는 단계;
(c) 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배지에 접종한 다음 배양한 후 멸균 처리하여 상기 (b) 단계를 완료한 수삼을 처리하기 위한 처리액을 준비하는 단계; 및
(d) 상기 (c) 단계에서 준비한 처리액에 상기 (b) 단계를 통하여 열처리한 수삼을 넣고 숙성하는 단계를 포함하는 것으로 특징으로 하는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법.
(a) pulverizing fresh ginseng to obtain a pulverized fresh ginseng;
(b) putting the pulverized fresh ginseng in a microwave-only container, closing the lid of the container, and performing heat treatment using a microwave;
(c) Lactobacillus inoculated with Bacillus Francisco taryum (Lactobacillus plantarum) MH16 in the medium, and then preparing a processing liquid for processing by a sterilization treatment and incubated complete the step (b) the fresh ginseng; And
(d) ginseno having excellent brain function and cognitive function improvement effect using ginseng, comprising the step of aging the heat-treated fresh ginseng through the (b) step to the treatment solution prepared in step (c). A method for preparing a composition rich in side Rg3, Rg5, and Rk1.
제 1항에 있어서,
상기 (b) 단계의 마이크로웨이브를 이용한 열처리는 500~5.000MHz의 주파수 마이크로웨이브에서 0.5 내지 5시간 동안 처리하는 것을 특징으로 하는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법.
The method of claim 1,
The heat treatment using the microwave in step (b) is ginsenoside Rg3 having excellent brain function and cognitive function improvement effect using ginseng, characterized in that the heat treatment using a microwave at a frequency of 500 to 5.000 MHz is processed for 0.5 to 5 hours, A method for preparing a composition rich in Rg5 and Rk1.
제 1항 또는 제 2항에 있어서,
상기 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 배양하기 위한 (c) 단계의 배지는
0.5 내지 1.5 (w/v)% peptone,
0.5 내지 1.5 (w/v)% beef extract,
0.5 내지 1.5 (w/v)% dipotassium hydrogen phosphate,
0.5 내지 1.5 (w/v)% triammonium citrate,
0.5 내지 1.5 (w/v)% magnesium sulfate heptahydrate,
7.0 내지 20.0 (w/v)% 무즙,
7.0 내지 20.0 (w/v)% 배즙,
잔부 (w/v)%의 증류수
를 포함하는 것을 특징으로 하는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법.
The method according to claim 1 or 2,
The Lactobacillus Francisco taryum medium of step (c) to a culture (Lactobacillus plantarum) has MH16
0.5 to 1.5 (w/v)% peptone,
0.5 to 1.5 (w/v)% beef extract,
0.5 to 1.5 (w/v)% dipotassium hydrogen phosphate,
0.5 to 1.5 (w/v)% triammonium citrate,
0.5 to 1.5 (w/v)% magnesium sulfate heptahydrate,
7.0 to 20.0 (w/v)% juice-free,
7.0-20.0 (w/v)% pear juice,
Balance (w/v)% of distilled water
A method for preparing a composition rich in ginsenosides Rg3, Rg5, and Rk1 having excellent brain function and cognitive function improvement effects using ginseng comprising a.
제 3항에 있어서,
상기 (c) 단계는 상기 배지 100중량부에 대하여 1.0 내지 10.0중량부로 상기 락토바실러스 프란타륨(Lactobacillus plantarum ) MH16을 접종한 다음 25 내지 45℃에서 10 내지 72시간 동안 배양하는 것을 특징으로 하는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법.
The method of claim 3,
Wherein the step (c) the ginseng which comprises culturing a 1.0 part to 10.0 parts by weight per 100 parts by weight of the medium inoculated with the Lactobacillus Francisco taryum (Lactobacillus plantarum) MH16 in the next 25 to 45 ℃ for 10 to 72 hours A method for preparing a composition rich in ginsenosides Rg3, Rg5, and Rk1, which are excellent in improving brain function and cognitive function by using.
제 1항 또는 제 2항에 있어서,
상기 (d) 단계의 숙성은 4 내지 30℃에서 10 내지 72시간 동안 이루어지는 것을 특징으로 하는 인삼을 이용하여 뇌기능 및 인지기능 개선 효과가 우수한 진세노사이드 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물 제조방법.
The method according to claim 1 or 2,
A composition rich in ginsenosides Rg3, Rg5, and Rk1 having excellent brain function and cognitive function improvement effects using ginseng, characterized in that the aging of step (d) is performed at 4 to 30°C for 10 to 72 hours Manufacturing method.
청구항 제1항의 제조방법에 의해 제조되어 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물을 유효성분으로 포함하는 것을 특징으로 하는 뇌기능 및 인지기능 개선 효과가 우수한 약학적 조성물.
A pharmaceutical composition excellent in improving brain function and cognitive function, characterized in that it contains a composition rich in Rg3, Rg5, and Rk1 as an active ingredient prepared by the manufacturing method of claim 1.
청구항 제1항의 제조방법에 의해 제조되어 Rg3, Rg5, Rk1을 풍부하게 함유한 조성물을 유효성분으로 포함하는 것을 특징으로 하는 뇌기능 및 인지기능 개선 효과가 우수한 건강식품 조성물.
A health food composition having excellent brain function and cognitive function improvement effect, characterized in that it contains a composition rich in Rg3, Rg5, and Rk1 as an active ingredient prepared by the manufacturing method of claim 1.
KR1020190074007A 2019-06-21 2019-06-21 Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng KR20200145254A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190074007A KR20200145254A (en) 2019-06-21 2019-06-21 Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190074007A KR20200145254A (en) 2019-06-21 2019-06-21 Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng

Publications (1)

Publication Number Publication Date
KR20200145254A true KR20200145254A (en) 2020-12-30

Family

ID=74088741

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190074007A KR20200145254A (en) 2019-06-21 2019-06-21 Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng

Country Status (1)

Country Link
KR (1) KR20200145254A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102549962B1 (en) * 2023-01-18 2023-06-30 최광태 Black ginseng product containing increased ginsenoside rg3, rg5, and rk1 and manufacturing method thereof
EP4226931A1 (en) * 2022-02-11 2023-08-16 Daedong Korea Ginseng Co., Ltd Method for producing black ginseng concentrate with increased prosapogenin ginsenoside content using immersion in plant extract, continuous steaming-drying technique and concenration with plate evaporator followed by heat treatment
CN117625477A (en) * 2023-11-30 2024-03-01 吉林省农业科学院(中国农业科技东北创新中心) Lactobacillus plantarum TRB14 and application thereof in preparing rare ginsenoside by fermenting and converting ginsenoside Rb1
CN117694541A (en) * 2023-12-14 2024-03-15 江苏新申奥生物科技有限公司 Probiotics composition for improving memory and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100665087B1 (en) 2004-12-07 2007-01-04 주식회사 진생사이언스 Composition comprising ginsenoside Rg5 and Rk1 for improving brain function and memory dysfunction
KR20130062628A (en) 2011-12-05 2013-06-13 주식회사 웰빙엘에스 Manufacturing method for fermentation red ginseng increasing ginsenoside rg3, rg5 and rk1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100665087B1 (en) 2004-12-07 2007-01-04 주식회사 진생사이언스 Composition comprising ginsenoside Rg5 and Rk1 for improving brain function and memory dysfunction
KR20130062628A (en) 2011-12-05 2013-06-13 주식회사 웰빙엘에스 Manufacturing method for fermentation red ginseng increasing ginsenoside rg3, rg5 and rk1

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4226931A1 (en) * 2022-02-11 2023-08-16 Daedong Korea Ginseng Co., Ltd Method for producing black ginseng concentrate with increased prosapogenin ginsenoside content using immersion in plant extract, continuous steaming-drying technique and concenration with plate evaporator followed by heat treatment
US12004548B2 (en) 2022-02-11 2024-06-11 Daedong Korea Ginseng Co., Ltd Method for producing black ginseng concentrate with increased prosapogenin ginsenoside content using continuous steaming-drying technique and combined concentration technology
KR102549962B1 (en) * 2023-01-18 2023-06-30 최광태 Black ginseng product containing increased ginsenoside rg3, rg5, and rk1 and manufacturing method thereof
CN117625477A (en) * 2023-11-30 2024-03-01 吉林省农业科学院(中国农业科技东北创新中心) Lactobacillus plantarum TRB14 and application thereof in preparing rare ginsenoside by fermenting and converting ginsenoside Rb1
CN117694541A (en) * 2023-12-14 2024-03-15 江苏新申奥生物科技有限公司 Probiotics composition for improving memory and preparation method thereof

Similar Documents

Publication Publication Date Title
KR20200145254A (en) Manufacturing method for a composition rich in ginsenosides Rg3, Rg5 and Rk1, which is excellent in improving brain function and cognitive function using ginseng
Kimaryo et al. The use of a starter culture in the fermentation of cassava for the production of “kivunde”, a traditional Tanzanian food product
CN102223806B (en) Method for preparing fermented tea using bacillus genus strain
US20190254313A1 (en) Fruit and vegetable juice rich in sod and processing method thereof
KR101832387B1 (en) Method for producing fermented korean cultivated wild ginseng with enhanced specific ginsenoside content using lactic acid bacteria
KR101904164B1 (en) Saccharomyces cerevisae SRCM100936 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof
CN103598358B (en) The method for making of fermented type hippophae rhamnoides tea
KR101402031B1 (en) Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154
CN108936164A (en) A kind of lactic acid bacteria rose enzyme beverage and preparation method thereof
CN109315656A (en) A kind of preparation method of multi-cultur es composite fermentation rose ferment
CN107788517B (en) Method for enhancing enzyme efficacy by using lactobacillus bulgaricus
CN107594416B (en) Processing method of fermented betel nuts
CN106635916A (en) Acetobacter orientalis YZD-09 and application thereof
KR20130107940A (en) Method of producing fermented red ginseng
CN105112327A (en) Method for separating bacilli and method for manufacturing fermented tea by aid of bacilli
KR102053735B1 (en) Black ginseng lactic acid bacteria fermentation composition and method for producing the same
KR102011133B1 (en) Lactobacillus plantarum MBE/L2990 strain having excellent alpha-rhamnosidase activity and bioconversion activity from ginsenoside Re and Rb1 to ginsenoside Rg1 and Rg5
Catherine et al. Evaluation of ogi (corn caramel) from maize and sorghum for isolation and characterisation of lactic acid bacteria (LAB)
US6106873A (en) Microflora and brine compositions for use in the production of uncooked stinky tofu (chaw-tofu) and method for producing uncooked stinky tofu (chaw-tofu)
KR101771488B1 (en) Novel Bacillus coagulans NRR1207, fermented ginseng using the same and probiotic composition containing the same
KR20020093690A (en) Production of honey beverage
KR102479410B1 (en) Method of preparation for fermented red ginseng having increased content of ginsenoside Compound K and fermented red ginseng using the same
KR101670321B1 (en) Manufacturing method of garlic extract of high quantity Cycloalliin
KR20190130247A (en) Saccharomyces cerevisae BA34 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof
KR20190130246A (en) Saccharomyces cerevisae BA31 strain for manufacturing the wine using various berries and not producing biogenic amine and uses thereof